NAPF is launching its Project Innovation, a national movement to accelerate the pace of cancer medical discovery.
The National Patient Advocate Foundation Foundation (NAPF) is launching its Project Innovation, a national movement to accelerate the pace of cancer medical discovery. The basis of the Project is outlined in its report “Securing the Future of Innovation in Cancer Treatment."
NAPF calls for an expansion on the science of innovation by streamlining logistical obstacles, which include bureaucratic, institutional, and regulatory; bolstering funding opportunities, which includes increased funding for for basic and clinical study, and heightened awareness by all stakeholders of clinical research opportunities; and improved communication and coordination between providers and patients, which focuses on enhancing enrollment of these clinical trials by improving physician awareness of clinical trials and sharing of information with their patients. The report says: "Coordination among oncology researchers, treating oncologists and patients is essential so that all parties are educated about ongoing research."
In addition, the report says regulatory policies must be established to ensure that payers cover clinical trial costs for patients.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.